400 likes | 535 Views
Carcinoma of the Cardia: Is there progress in the management of non-Barrett’s cancer. XXIV Congress. Spanish Association of Surgeons Madrid 11 November 2002. The University of Hong Kong. Adenocarcinoma of Esophagogastric Junction. Reflux esophagitis is rare in Asia
E N D
Carcinoma of the Cardia: Is there progress in the management of non-Barrett’s cancer XXIV Congress Spanish Association of Surgeons Madrid 11 November 2002 The University of Hong Kong
Adenocarcinoma of Esophagogastric Junction • Reflux esophagitis is rare in Asia • Barrett’s esophagus and cancer are clinical curiosities • One Chinese patient out of 1,200 resections had Barrett’s cancer • Adenocarcinoma of cardia and proximal stomach is a continuum
Adenocarcinoma of Esophagogastric Junction • Presentation is late, with anaemia followed by dysphagia • Resection is mostly palliative • CT or CTRT is undergoing trials • Survival has not increased significantly over the last two decades
Olmsted County 1974-1989 Cases / 100,000 / yr Squamous Adeno (GEJ) Adeno (ESO) Pera et al, Gastroenterology, 1993
Controversy Does type II behave as type I (esophageal) or type III (gastric) ?
Adenocarcinoma of Esophagogastric Junction Adenocarcinoma of the distal esophagus and gastric cardia are one clinical entity Wijnhoven et al, BJS, 1999
No. at risk Total 252 175 100 62 42 25 Oesophagus 111 76 43 25 18 12 Gastric cardia 141 99 57 37 24 13 Wijnhoven et al, BJS, 1999
Adenocarcinoma of Esophagogastric Junction Tumors spreads to thoracic and abdominal lymph nodes Staging as esophageal or gastric cancers makes no different in survival Suggested that these tumors behaves like esophageal cancer Steup et al, J Thorac Cardiovasc Surg, 1996
Adenocarcinoma of the Esophagogastric Junction Type II cancers can be treated by abdominal gastrectomy Siewert et al, Ann Surg, 2000
Adenocarcinoma of Esophagogastric Junction Limited Resection for Carcinoma of Cardia 1970 – 1988; 149 patients Ellis et al, Ann Surg, 1988
Adenocarcinoma of Esophagogastric Junction Proximal gastrectomy should be performed for upper third gastric cancer when invasion is confined to muscularis propria Kitamura et al, Surg Today, 1997
Adenocarcinoma of Esophagogastric Junction Total gastrectomy is not necessary for proximal gastric cancer Harrison et al, Surgery, 1998
Adenocarcinoma of Esophagogastric Junction After resection of proximal gastric cancer, use of gastric tube is the best reconstruction Shiraishi et al, WJS, 2002
Adenocarcinoma of Esophagogastric Junction An operation based on “epi-centre” of tumor is appropriate and can be performed safely and with acceptable survival Fein et al, Surgery, 1998
Adenocarcinoma of Esophagogastric Junction Main Treatment (%)
Adenocarcinoma of Esophagogastric Junction Main Treatment (%)
Adenocarcinoma of Esophagogastric Junction Overall Resection 70% CT / RT 8% Intubation 2% No treatment 11%
Adenocarcinoma of Esophagogastric Junction Site of Anastomosis (%)
Adenocarcinoma of Esophagogastric Junction Resection Margin and Anastomotic Site
Adenocarcinoma of Esophagogastric Junction Resection Margin and Recurrence
Adenocarcinoma of Esophagogastric Junction Complications (%)
Survival After Resection ADC N=223
Survival After Resection SCC N=855
Adenocarcinoma of Esophagogastric Junction Mortality (%)
Adenocarcinoma of Esophagogastric Junction Mortality and Morbidity (%) Major complications No differences
Survival after Resection ADC (N = 223) p = 0.4838
Adenocarcinoma of Esophagogastric Junction Survival – ADC 223 Resections
Survival after Resection ADC (N = 223) p < 0.01
Survival after Resection ADC (N = 223) p = 0.2850
Evolution of Treatment & Outcome 1970-2001 Patients 1097 Curative resection 994 Survivors 879 1970-1985 246 (Group 1) 1986-1996 465 (Group 2) 1997-2001 283 (Group 3) 1997-2001 230 (HKU) Hofstetter et al, Ann Surg, 2002
Evolution of Treatment & Outcome Group 1 Group 2 Group 3 HKU M / F 2/1 4/1 8/1 5/1 ADC / SCC (%) 29/71 66/32 83/17 27/73 M1/3 / L1/3 (%) 34/44 19/74 13/86 44/19 Hofstetter et al, Ann Surg, 2002
Evolution of Treatment & Outcome Group 1 Group 2 Group 3 HKU Transhiatal (%) 7 29 33 0.4 Gastric conduit (%) 64 97 99 94 Neoadjuvant CT (%) 2 33 5 5 RT (%) 51 3 1 0 CTRT (%) 2 10 59 27 Hofstetter et al, Ann Surg, 2002
Evolution of Treatment & Outcome Group 1 Group 2 Group 3 HKU Hospital mortality (%) 12 5 6 0 Leakage (%) 10 10 6 4 R0 resection (%) 78 87 94 72 Recurrence (%) 43 49 33 57 Survival Median (m) 13 21 32 20 3 yr (%) 27 34 46 33 Hofstetter et al, Ann Surg, 2002
Survival after Resection University of Texas n=1097 University of Hong Kong n=1094 p < 0.01
Conclusions • Carcinoma of cardia presents late • Complications of operations are less than SCC • Mortality can be reduced to zero • Thoracotomy does not add risks • Prognosis same in SCC & ADC • Systemic CT or CTRT may have benefit • Regional CT may be superior • Prediction of response important to determine